Get 30% off on all global market reports with code ONLINE30 – stay updated on tariff changes, macroeconomic trends, and more!
Knee Bursitis Market Size in 2029: A Look at Recent Changes and Trends
The market size for knee bursitis has witnessed robust expansion in the preceding years. The forecast suggests that the market will elevate from a valuation of $2.66 billion in 2024 to reach $2.86 billion by 2025, moving with a compound annual growth rate (CAGR) of 7.3%. Factors like an aging demographic, augmented involvement in sports and physical activities, enhanced diagnostic measures, bettered access to healthcare amenities, and educational initiatives for healthcare providers and patients have contributed to the growth in the historic period.
Expectations are high for substantial expansion in the knee bursitis market in the upcoming years, with projections reaching $3.72 billion by 2029, increasing at a compound annual growth rate (CAGR) of 6.8%. Factors contributing to this projected growth span from heightened campaigns on prevention and management, an increase in disposable income, soaring health care spending, and a rise in awareness and diagnosis of knee bursitis. Key trends predicted for this period encompass advances in diagnostic procedures, the creation of new therapies, progress in research and development efforts, and the rise of telemedicine and remote monitoring.
Claim Your Free Sample Report:
http://www.thebusinessresearchcompany.com/sample….p;type=smp
Key Drivers Behind the Expansion of the Knee Bursitis Market: Insights and Trends
The escalating rate of skeletal-related conditions is likely to motivate the expansion of the knee bursitis market in the future. These conditions include ailments like osteoporosis, arthritis, and bone cancer, which impact the structure, sturdiness, and operations of the skeletal framework. The surge in frequency of these diseases are associated with aspects such as aging populations, inactive behaviors, malnutrition, and alterations in surroundings. Conditions like osteoarthritis and rheumatoid arthritis can result in knee bursitis by instigating inflammation and excessive strain on the knee bursa, causing pain, swelling, and diminished joint function.
For example, a report from Healthy Bones Australia, a non-profit organization based in Australia, predicted in September 2022 that around 6.2 million individuals of age 50 and above will be affected by osteoporosis or osteopenia in 2022. This estimation is derived considering that 22% are affected by osteoporosis and 78% by osteopenia out of the 4.74 million Australians with poor bone health. Therefore, the escalating rate of skeletal-related diseases is fueling the expansion of the knee bursitis market.
Which Segments in the Knee Bursitis Industry Are Seeing the Fastest Growth?
The knee bursitismarket covered in this report is segmented –
1) By Diagnosis: Imaging Test; Other Diagnosis Tests
2) By Treatment: Medication; Therapy; Surgery; Other Treatments
3) By End User: Hospitals And Clinics; Diagnostic Centers; Research Centers; Academic Institutes; Other End Users
Subsegments:
1) By Imaging Test: X-Ray; MRI (Magnetic Resonance Imaging); Ultrasound
2) By Other Diagnosis Tests: Physical Examination; Aspiration Of Joint Fluid; Blood Tests
Access the Full Report Today:
http://www.thebusinessresearchcompany.com/report/…ket-report
Which Global Regions Are Powering Demand in the Knee Bursitis Market?
North America was the largest region in the knee bursitis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the knee bursitis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get a Customized Version of the Report:
http://www.thebusinessresearchcompany.com/customi…p;type=smp
How Key Players Are Driving Growth in the Knee Bursitis Market?
Major companies operating in the knee bursitis market are Pfizer Inc., Merck & Co. Inc, Bayer AG, Novartis AG, Roche Holding AG, Medtronic plc, Eli Lilly and Company, Amgen Inc, Gilead Sciences Inc., Stryker Corporation, Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Incorporated, Zimmer Biomet Holdings Inc., DePuy Synthes Inc., Arthrex Inc., Globus Medical Inc., Bioventus LLC, Exactech Inc., Genentech Inc., Conformis Inc., Oncolys BioPharma Inc, Bellicum Pharmaceuticals Inc, Merrimack Pharmaceuticals Inc, 4Med Medical Solutions Inc
Access the Complete Report:
http://www.thebusinessresearchcompany.com/purchas…x?id=16460
How Our Market Research Reports Help Maximize ROI Across Industries:
* Identify High-Growth Opportunities: Pinpoint emerging trends, untapped segments, and regional hotspots that align with your strategic goals.
* Reduce Investment Risk: Make data-driven decisions with confidence by understanding market dynamics, key drivers, and competitive threats.
* Optimize Strategic Planning: Align your product development, marketing, and expansion plans with industry forecasts and customer behaviour insights.
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
News From
The Business Research Company …
Category: Industry Reports & Market Analysis Profile: The Business Research Company is a leading market research and consulting services provider. It offers over 9,500 market reports across 27 industries in 60+ geographies, providing detailed insights and forecasts. Its customised research solutions support companies in making critical decisions, while its continuous research service enhances organizational capabilities. The flagship Global Market Model database provides comprehensive market intelligence with 1,500,000 datasets covering 8,000+ mark …
This email address is being protected from spambots. You need JavaScript enabled to view it.
